Skip to main content
. 2017 Jun 14;142(3):444–455. doi: 10.1111/jnc.14071

Figure 2.

Figure 2

Corticosterone (CORT) pretreatment exacerbates chlorpyrifos oxon (CPO)‐induced neuroinflammation. Effects of CPO exposure (8 mg/kg, i.p.) with and without prior CORT treatment (400 mg/L, 1.2% EtOH) on neuroinflammation as measured by qPCR of inflammatory cytokines and chemokines at 6 h post‐CPO. Tumor necrosis factor‐alpha (TNFα), IL‐6, (C–C) chemokine ligand 2 (CCL2), IL‐1b, leukemia inhibitory factor (LIF), and oncostatin M (OSM) were measured in cortex (left panels) and hippocampus (right panels). Data represents mean ± SEM (N = 4–6 mice/group). Statistical significance of at least p ≤ 0.05 is denoted by * compared with relevant control (vehicle or CORT) and # compared with treatment (saline or CPO).